Abstract
Purpose
To develop a novel method for the preparation of thiolated polyacrylic acid nanoparticles via ionic gelation.
Materials and Methods
In a first step nanoparticles were generated by ionotropic gelation of polyacrylic acid (PAA) of three different molecular weights (100, 240 and 450 kDa) and various cations including Ca2+, Mg2+, Zn2+, Al3+ and Fe3+. Via in vitro characterization of the particles (particle size, size distribution and zeta potential) the optimal preparation conditions were established. Taking into consideration, that thiolated polyacrylic acid (PAA-Cys) displays higher mucoadhesive and permeation enhancing properties than unmodified PAA, PAA-Cys nanoparticles were produced in the same manner with Ca2+, as the most promising results concerning particle size and stability of particles could be achieved with this ionic crosslinker. The nanoparticles were stabilized via the formation of inter- and intrachain disulfide bonds within these particles due to oxidation with H2O2. Ca2+ was removed proximately by the addition of EDTA and exhaustive dialysis.
Results
Using the preparation method described above PAA-Cys nanoparticles of a mean diameter of about 220 nm (PAA100-Cys), 250 nm (PAA240-Cys) and 295 nm (PAA450-Cys) can be generated. In comparison to PAA nanoparticles ionically crosslinked with Ca2+, the removal of the crosslinker Ca2+ from PAA-Cys particles led to a nearly three-fold decrease in the zeta potential, from about −7 up to −20 mV. Apart from this advantage, covalently crosslinked PAA-Cys nanoparticles were more firm as they remained stable when incubated in hydrochloride solution, whereas ionically crosslinked particles dissolved at pH lower than 5.
Conclusions
This novel nanoparticulate delivery system seems to be a promising vehicle for the administration of therapeutic proteins, genes and antigens via mucosal membranes.
Similar content being viewed by others
References
A. J. Coupe, S. S. Davis, and I. R. Wilding. Variation in gastrointestinal transit of pharmaceutical dosage forms in healthy subjects. Pharm Res. 8:360–364 (1991).
G. Ponchel and J. Irache. Specific and non-specific bioadhesive particulate systems for oral delivery to the gastrointestinal tract. Adv. Drug Deliv. Rev. 34:191–219 (1998).
T. Kubik, K. Bogunia-Kubik, and M. Sugisaka. Nanotechnology on duty in medical applications. Curr. Pharm. Biotechnol. 6:17–33 (2005).
B. Kriwet, E. Walter, and T. Kissel. Synthesis of bioadhesive poly(acrylic acid) nano- and microparticles using an inverse emulsion polymerization method for the entrapment of hydrophilic drug candidates. J. Control. Release 56:149–158 (1998).
S. Ribeiro, N. Hussain, and A. T. Florence. Release of DNA from dendriplexes encapsulated in PLGA nanoparticles. Int. J. Pharm. 298:354–360 (2005).
S. A. Agnihotri, N. N. Mallikarjuna, and T. M. Aminabhavi. Recent advances on chitosan-based micro- and nanoparticles in drug delivery. J. Control. Release 100:5–28 (2004).
N. A. Peppas and P. A. Buri. Surface interfacial and molecular aspects of polymer bioadhesion on soft tissues. J. Control. Release 2:257–275 (1985).
D. E. Chickering III and E. Mathiowitz. Definitions, mechanisms, and theories of bioadhesion. Drugs Pharm. Sci. 98:1–10 (1999).
V. Grabovac, D. Guggi, and A. Bernkop-Schnürch. Comparison of the mucoadhesive properties of various polymers. Adv. Drug Deliv. Rev. 57:1713–1723 (2005).
M. Roldo, M. Hornof, P. Caliceti, and A. Bernkop-Schnürch. Mucoadhesive thiolated chitosans as platforms for oral controlled drug delivery: synthesis and in vitro evaluation. Eur. J. Pharm. Biopharm. 57:115–121 (2004).
V. M. Leitner, D. Guggi, A. H. Krauland, and A. Bernkop-Schnürch. Nasal delivery of human growth hormone: in vitro and in vivo evaluation of a thiomer/glutathione microparticulate delivery system. J. Control. Release 100:87–95 (2004).
M. K. Marschütz and A. Bernkop-Schnürch. Thiolated polymers: self-crosslinking properties of thiolated 450 kDa poly(acrylic acid) and their influence on mucoadhesion. Eur. J. Pharm. Sci. 15:387–394 (2002).
A. Bernkop-Schnürch, V. Schwarz, and S. Steininger. Polymers with thiol groups: a new generation of mucoadhesive polymers? Pharm Res. 16:876–881 (1999).
A. F. Habeeb. A sensitive method for localization of disulfide containing peptides in column effluents. Anal. Biochem. 56:60–65 (1973).
C. E. Kast and A. Bernkop-Schnürch. Thiolated polymers: development and in vitro evaluation of chitosan-thioglycolic acid conjugates. Biomaterials 22:2345–2352 (2001).
A. Bernkop-Schnürch and M. E. Krajicek. Mucoadhesive polymers as platforms for peroral peptide delivery and absorption: synthesis and evaluation of different chitosan-EDTA conjugates. J. Control. Release 50:215–223 (1998).
T. K. De, D. J. Rodman, B. A. Holm, P. N. Prasad, and E. J. Bergey. Brimonidine formulation in polyacrylic acid nanoparticles for ophthalmic delivery. J. Microencapsul. 20:361–374 (2003).
B. Kriwet, E. Walter, and T. Kissel. Synthesis of bioadhesive poly(acrylic acid) nano- and microparticles using an inverse emulsion polymerization method for the entrapment of hydrophilic drug candidates. J. Control. Release 56:149–158 (1998).
P. Calvo, C. Remunáz-López, J. L. Vila-Jato, and M. J. Alonso. Novel hydrophilic chitosan-polyethylene oxide nanoparticles as protein carriers. J. Appl. Polym. Sci. 63:125–132 (1997).
M. Rajaonarivony, C. Vauthier, G. Couarraze, F. Puisieux, and P. Couvreur. Development of a new drug carrier made from alginate. J. Pharm. Sci. 82:912–917 (1993).
K. L. Douglas and M. Tabrizian. Effect of experimental parameters on the formation of alginate–chitosan nanoparticles and evaluation of their potential application as DNA carrier. J. Biomater. Sci. Polym. Ed. 16:43–56 (2005).
T. K. Bronich, P. A. Keifer, L. S. Shlyakhtenko, and A. V. Kabanov. Polymer micelle with cross-linked ionic core. J. Am. Chem. Soc. 127:8236–8237 (2005).
A. E. Clausen and A. Bernkop-Schürch. In vitro evaluation of the permeation-enhancing effect of thiolated polycarbophil. J. Pharm. Sci. 89:1253–1261 (2000).
A. Bernkop-Schnürch, H. Zarti, and G. F. Walker. Thiolation of polycarbophil enhances its inhibition of soluble and intestinal brush border membrane bound aminopeptidase N. J. Pharm. Sci. 90:1907–1914 (2001).
A. Bernkop-Schnürch and S. Thaler. Polycarbophil–cysteine conjugates as platforms for oral (poly)peptide delivery systems. J. Pharm. Sci. 89:901–909 (2000).
A. Bernkop-Schnürch, A. Weithaler, K. Albrecht, and A. Greimel. Thiomers: Preparation and in vitro evaluation of a mucoadhesive nanoparticulate drug delivery system. Int. J. Pharm. 317:76–81 (2006).
K. Albrecht, E. J. Zirm, W. Schlocker, and A. Bernkop-Schnürch. Preparation of thiomer particles and in vitro evaluation of parameters influencing their mucoadhesive properties. Drug Dev. Ind. Pharm. (In press).
D. Guggi, M. K. Marschütz, and A. Bernkop-Schnürch. Matrix tablets based on thiolated poly(acrylic acid): pH-dependent variation in disintegration and mucoadhesion. Int. J. Pharm. 274:97–105 (2004).
A. Lamprecht, U. Schafer, and C. M. Lehr. Size-dependent bioadhesion of micro- and nanoparticulate carriers to the inflamed colonic mucosa. Pharm Res. 18:788–793 (2001).
P. Younessi, M. R. Avadi, K. Shamimi, A. M. Sadeghi, L. Moezi, E. Nahid, K. Bayati, A. R. Dehpour, and M. Rafiee-Tehrani. Preparation and ex vivo evaluation of TEC as an absorption enhancer for poorly absorbable compounds in colon specific drug delivery. Acta Pharm. 54:339–345 (2004).
Acknowledgment
This work was supported by a Grant from the Austria Nano Initiative to A. Bernkop-Schnürch.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Greindl, M., Bernkop-Schnürch, A. Development of a Novel Method for the Preparation of Thiolated Polyacrylic Acid Nanoparticles. Pharm Res 23, 2183–2189 (2006). https://doi.org/10.1007/s11095-006-9087-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11095-006-9087-1